CIK 0001752828 · <br>Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831702591
- Phone
- (908) 768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Medical Officer gave up 52,762 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 70,350 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 43,968 shares (to pay taxes)
- 4 Shares withheld for taxes Pres, Functional Regeneration gave up 32,720 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 39,571 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy 10% owner bought 21,410,983 shares at $0.25 ($5,331,335)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Unregistered share sale · Executive or director change
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- 8-K Event Delisting notice
- NT 10-Q Other NT 10-Q
Page 10 of 29 · 563 filings